KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Inventory (2016 - 2025)

Eli Lilly's Inventory history spans 17 years, with the latest figure at $13.7 billion for Q4 2025.

  • For Q4 2025, Inventory rose 81.1% year-over-year to $13.7 billion; the TTM value through Dec 2025 reached $13.7 billion, up 81.1%, while the annual FY2025 figure was $13.7 billion, 81.1% up from the prior year.
  • Inventory reached $13.7 billion in Q4 2025 per LLY's latest filing, up from $12.2 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $13.7 billion in Q4 2025 to a low of $3.7 billion in Q1 2021.
  • Average Inventory over 5 years is $6.3 billion, with a median of $4.9 billion recorded in 2023.
  • Peak YoY movement for Inventory: decreased 2.37% in 2021, then skyrocketed 81.1% in 2025.
  • A 5-year view of Inventory shows it stood at $3.9 billion in 2021, then rose by 10.9% to $4.3 billion in 2022, then surged by 33.95% to $5.8 billion in 2023, then surged by 31.46% to $7.6 billion in 2024, then surged by 81.1% to $13.7 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Inventory are $13.7 billion (Q4 2025), $12.2 billion (Q3 2025), and $11.0 billion (Q2 2025).